Evidence map›Paper›PMID 32457142›Full record

ArticleProceedings of the National Academy of Sciences of the United States of America2020

Prosocial polio vaccination in Israel.

Chad R Wells, Amit Huppert, Meagan C Fitzpatrick, Abhishek Pandey, Baruch Velan, Burton H Singer, Chris T Bauch, Alison P Galvani

Open access · hybridAbstract read
In one paragraph

Article in Proceedings of the National Academy of Sciences of the United States of America, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed, 1 pooled it
2.6field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 1 synthesis or guideline pooled it, 28 citations in OpenAlex.

  1. Pooled it
  2. Trial
  3. Article
  4. Into the "New Normal": The Ethical and Analytical Challenge Facing Public Health Post-COVID-19.International journal of environmental research and public health · 2022
    Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 6 institutions in 3 countries.

Chad R WellsCenter for Infectious Disease Modeling and Analysis, Yale School of Public Health, New Haven, CT 06520.ORCID 0000-0003-1370-8350
Amit HuppertThe Biostatistics & Biomathematics Unit, The Gertner Institute for Epidemiology and Health Policy Research, Sheba Medical Center, Tel Hashomer, 52621 Ramat Gan, Israel.
Meagan C FitzpatrickCenter for Infectious Disease Modeling and Analysis, Yale School of Public Health, New Haven, CT 06520.
Abhishek PandeyCenter for Infectious Disease Modeling and Analysis, Yale School of Public Health, New Haven, CT 06520.
Baruch VelanThe Biostatistics & Biomathematics Unit, The Gertner Institute for Epidemiology and Health Policy Research, Sheba Medical Center, Tel Hashomer, 52621 Ramat Gan, Israel.
Burton H SingerEmerging Pathogens Institute, University of Florida, Gainesville, FL 32610; bhsinger@epi.ufl.edu.
Chris T BauchDepartment of Applied Mathematics, University of Waterloo, Waterloo, ON N2L 3G1, Canada.
Alison P GalvaniCenter for Infectious Disease Modeling and Analysis, Yale School of Public Health, New Haven, CT 06520.
Yale University · USSheba Medical Center · ILTel Aviv University · ILUniversity of Florida · USUniversity of Maryland, Baltimore · USUniversity of Waterloo · CA

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Regions with insufficient vaccination have hindered worldwide poliomyelitis eradication, as they are vulnerable to sporadic outbreaks through reintroduction of the disease. Despite Israel's having been declared polio-free in 1988, a routine sewage surveillance program detected polio in 2013. To curtail transmission, the Israel Ministry of Health launched a vaccine campaign to vaccinate children-who had only received the inactivated polio vaccine-with the oral polio vaccine (OPV). Determining the degree of prosocial motivation in vaccination behavior is challenging because vaccination typically provides direct benefits to the individual as well as indirect benefits to the community by curtailing transmission. However, the Israel OPV campaign provides a unique and excellent opportunity to quantify and model prosocial vaccination as its primary objective was to avert transmission. Using primary survey data and a game-theoretical model, we examine and quantify prosocial behavior during the OPV campaign. We found that the observed vaccination behavior in the Israeli OPV campaign is attributable to prosocial behavior and heterogeneous perceived risk of paralysis based on the individual's comprehension of the prosocial nature of the campaign. We also found that the benefit of increasing comprehension of the prosocial nature of the campaign would be limited if even 24% of the population acts primarily from self-interest, as greater vaccination coverage provides no personal utility to them. Our results suggest that to improve coverage, communication efforts should also focus on alleviating perceived fears surrounding the vaccine.

Indexed as

AltruismAdolescentAdultAgedChildDisease OutbreaksGame TheoryHumansImmunization ProgramsIsraelMass VaccinationMiddle AgedModels, NeurologicalPoliomyelitisPoliovirusPoliovirus Vaccine, InactivatedPoliovirus Vaccine, InactivatedPoliovirus Vaccine, OralSewagealtruismdisease preventiongame theoryvaccination motives

Identifiers

PMID32457142
PMCPMC7293608
OpenAlexW3029580763

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.